Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration

Background: Glioma is the result of malignant transformation of glial cells in the white matter of the brain or spinal cord and accounts for approximately 80% of all intracranial malignancies. Cathepsin A (CTSA) is highly expressed in a variety of tumor tissues, but its role in glioma is poorly stud...

Full description

Bibliographic Details
Main Authors: Zhang Ming, Huang Jun, Wang Yunfei, Nie Qingbin, Zhang Xinye, Yang Yufeng, Mao Gengsheng
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2022-01-01
Series:Journal of Medical Biochemistry
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2022/1452-82582204459Z.pdf
_version_ 1811194247929397248
author Zhang Ming
Huang Jun
Wang Yunfei
Nie Qingbin
Zhang Xinye
Yang Yufeng
Mao Gengsheng
author_facet Zhang Ming
Huang Jun
Wang Yunfei
Nie Qingbin
Zhang Xinye
Yang Yufeng
Mao Gengsheng
author_sort Zhang Ming
collection DOAJ
description Background: Glioma is the result of malignant transformation of glial cells in the white matter of the brain or spinal cord and accounts for approximately 80% of all intracranial malignancies. Cathepsin A (CTSA) is highly expressed in a variety of tumor tissues, but its role in glioma is poorly studied. This study analyses the relationship between CTSA, and glioma based on The Cancer Genome Atlas (TCGA). Methods: Data for glioma patients were collected from TCGA. The expression level of CTSA was compared between paired glioma tissues and normal tissues with Wilcoxon rank-sum test. In addition, the Wilcoxon ranksum test was also applied to analyze the relationship between clinicopathologic features and CTSA expression. Kaplan-Meier Plotter was applied to analyze OS, DSS and PFI. Immuno-infiltration analysis of BLCA was performed by single sample gene set enrichment analysis (ssGSEA) in the "GSVA" R package. Results: The CTSA was overexpressed in glioma tissues compared to normal tissues (P<0.001). The high expression of CTSA was significantly related to 1p/19q codeletion, IDH, WHO grade and histological type. Kaplan-Meier survival analysis showed that patients with glioma characterized with high expressed CTSA had a poorer OS (HR=2.16 P<0.001), DSS (HR=2.17 P<0.001) and PFI (HR=1.48 P<0.001) than patients with low CTSA expression. Moreover, High expressed CTSA was associated with immune cell infiltration. Conclusions: CTSA may serve as a candidate prognostic biomarker for determining prognosis associated with immune infiltration in glioma.
first_indexed 2024-04-12T00:22:46Z
format Article
id doaj.art-d60c3dfd273a4ac68957c446804a315a
institution Directory Open Access Journal
issn 1452-8258
1452-8266
language English
last_indexed 2024-04-12T00:22:46Z
publishDate 2022-01-01
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format Article
series Journal of Medical Biochemistry
spelling doaj.art-d60c3dfd273a4ac68957c446804a315a2022-12-22T03:55:40ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662022-01-0141445946510.5937/jomb0-356771452-82582204459ZCathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltrationZhang Ming0Huang Jun1Wang Yunfei2Nie Qingbin3Zhang Xinye4Yang Yufeng5Mao Gengsheng6The Third Medical Centre Chinese PLA (People's Liberation Army) General Hospital, Department of Neurosurgery, Beijing, ChinaThe Third Medical Centre Chinese PLA (People's Liberation Army) General Hospital, Department of Neurosurgery, Beijing, ChinaThe Third Medical Centre Chinese PLA (People's Liberation Army) General Hospital, Department of Neurosurgery, Beijing, ChinaThe Third Medical Centre Chinese PLA (People's Liberation Army) General Hospital, Department of Neurosurgery, Beijing, ChinaThe Third Medical Centre Chinese PLA (People's Liberation Army) General Hospital, Department of Neurosurgery, Beijing, ChinaThe Third Medical Centre Chinese PLA (People's Liberation Army) General Hospital, Department of Neurosurgery, Beijing, ChinaThe Third Medical Centre Chinese PLA (People's Liberation Army) General Hospital, Department of Neurosurgery, Beijing, ChinaBackground: Glioma is the result of malignant transformation of glial cells in the white matter of the brain or spinal cord and accounts for approximately 80% of all intracranial malignancies. Cathepsin A (CTSA) is highly expressed in a variety of tumor tissues, but its role in glioma is poorly studied. This study analyses the relationship between CTSA, and glioma based on The Cancer Genome Atlas (TCGA). Methods: Data for glioma patients were collected from TCGA. The expression level of CTSA was compared between paired glioma tissues and normal tissues with Wilcoxon rank-sum test. In addition, the Wilcoxon ranksum test was also applied to analyze the relationship between clinicopathologic features and CTSA expression. Kaplan-Meier Plotter was applied to analyze OS, DSS and PFI. Immuno-infiltration analysis of BLCA was performed by single sample gene set enrichment analysis (ssGSEA) in the "GSVA" R package. Results: The CTSA was overexpressed in glioma tissues compared to normal tissues (P<0.001). The high expression of CTSA was significantly related to 1p/19q codeletion, IDH, WHO grade and histological type. Kaplan-Meier survival analysis showed that patients with glioma characterized with high expressed CTSA had a poorer OS (HR=2.16 P<0.001), DSS (HR=2.17 P<0.001) and PFI (HR=1.48 P<0.001) than patients with low CTSA expression. Moreover, High expressed CTSA was associated with immune cell infiltration. Conclusions: CTSA may serve as a candidate prognostic biomarker for determining prognosis associated with immune infiltration in glioma.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2022/1452-82582204459Z.pdfcathepsin agliomaprognostic biomarkerimmune infiltration
spellingShingle Zhang Ming
Huang Jun
Wang Yunfei
Nie Qingbin
Zhang Xinye
Yang Yufeng
Mao Gengsheng
Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
Journal of Medical Biochemistry
cathepsin a
glioma
prognostic biomarker
immune infiltration
title Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
title_full Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
title_fullStr Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
title_full_unstemmed Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
title_short Cathepsin a upregulation in glioma: A potential therapeutic target associated with immune infiltration
title_sort cathepsin a upregulation in glioma a potential therapeutic target associated with immune infiltration
topic cathepsin a
glioma
prognostic biomarker
immune infiltration
url https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2022/1452-82582204459Z.pdf
work_keys_str_mv AT zhangming cathepsinaupregulationingliomaapotentialtherapeutictargetassociatedwithimmuneinfiltration
AT huangjun cathepsinaupregulationingliomaapotentialtherapeutictargetassociatedwithimmuneinfiltration
AT wangyunfei cathepsinaupregulationingliomaapotentialtherapeutictargetassociatedwithimmuneinfiltration
AT nieqingbin cathepsinaupregulationingliomaapotentialtherapeutictargetassociatedwithimmuneinfiltration
AT zhangxinye cathepsinaupregulationingliomaapotentialtherapeutictargetassociatedwithimmuneinfiltration
AT yangyufeng cathepsinaupregulationingliomaapotentialtherapeutictargetassociatedwithimmuneinfiltration
AT maogengsheng cathepsinaupregulationingliomaapotentialtherapeutictargetassociatedwithimmuneinfiltration